1. Home
  2. PETS vs MDXH Comparison

PETS vs MDXH Comparison

Compare PETS & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$1.85

Market Cap

38.0M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.54

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PETS
MDXH
Founded
1996
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
41.1M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
PETS
MDXH
Price
$1.85
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
195.7K
1.3M
Earning Date
06-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$273,800,000.00
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
$2.98
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$0.51
52 Week High
$4.10
$5.33

Technical Indicators

Market Signals
Indicator
PETS
MDXH
Relative Strength Index (RSI) 38.13 17.40
Support Level $1.62 $0.51
Resistance Level $2.41 $3.78
Average True Range (ATR) 0.13 0.08
MACD -0.02 0.04
Stochastic Oscillator 33.56 11.07

Price Performance

Historical Comparison
PETS
MDXH

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: